Literature DB >> 21055385

The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5).

Sang-Choul Im1, Lucy Waskell.   

Abstract

Cytochrome P450 2B4 is a microsomal protein with a multi-step reaction cycle similar to that observed in the majority of other cytochromes P450. The cytochrome P450 2B4-substrate complex is reduced from the ferric to the ferrous form by cytochrome P450 reductase. After binding oxygen, the oxyferrous protein accepts a second electron which is provided by either cytochrome P450 reductase or cytochrome b(5). In both instances, product formation occurs. When the second electron is donated by cytochrome b(5), catalysis (product formation) is ∼10- to 100-fold faster than in the presence of cytochrome P450 reductase. This allows less time for side product formation (hydrogen peroxide and superoxide) and improves by ∼15% the coupling of NADPH consumption to product formation. Cytochrome b(5) has also been shown to compete with cytochrome P450 reductase for a binding site on the proximal surface of cytochrome P450 2B4. These two different effects of cytochrome b(5) on cytochrome P450 2B4 reactivity can explain how cytochrome b(5) is able to stimulate, inhibit, or have no effect on cytochrome P450 2B4 activity. At low molar ratios (<1) of cytochrome b(5) to cytochrome P450 reductase, the more rapid catalysis results in enhanced substrate metabolism. In contrast, at high molar ratios (>1) of cytochrome b(5) to cytochrome P450 reductase, cytochrome b(5) inhibits activity by binding to the proximal surface of cytochrome P450 and preventing the reductase from reducing ferric cytochrome P450 to the ferrous protein, thereby aborting the catalytic reaction cycle. When the stimulatory and inhibitory effects of cytochrome b(5) are equal, it will appear to have no effect on the enzymatic activity. It is hypothesized that cytochrome b(5) stimulates catalysis by causing a conformational change in the active site, which allows the active oxidizing oxyferryl species of cytochrome P450 to be formed more rapidly than in the presence of reductase.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055385      PMCID: PMC3073529          DOI: 10.1016/j.abb.2010.10.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  50 in total

1.  Natural engineering principles of electron tunnelling in biological oxidation-reduction.

Authors:  C C Page; C C Moser; X Chen; P L Dutton
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

2.  The morph server: a standardized system for analyzing and visualizing macromolecular motions in a database framework.

Authors:  W G Krebs; M Gerstein
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

3.  Pivotal role of water in the mechanism of P450BM-3.

Authors:  D C Haines; D R Tomchick; M Machius; J A Peterson
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

4.  Deletion of microsomal cytochrome b5 profoundly affects hepatic and extrahepatic drug metabolism.

Authors:  Lesley A McLaughlin; Sebastien Ronseaux; Robert D Finn; Colin J Henderson; C Roland Wolf
Journal:  Mol Pharmacol       Date:  2010-04-29       Impact factor: 4.436

5.  Hydroxylation of camphor by reduced oxy-cytochrome P450cam: mechanistic implications of EPR and ENDOR studies of catalytic intermediates in native and mutant enzymes.

Authors:  R Davydov; T M Makris; V Kofman; D E Werst; S G Sligar; B M Hoffman
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

6.  Hydrogen-bonding interactions in the active sites of cytochrome P450cam and its site-directed mutants.

Authors:  T Deng ; I D Macdonald; M C Simianu; M Sykora; J R Kincaid; S G Sligar
Journal:  J Am Chem Soc       Date:  2001-01-17       Impact factor: 15.419

7.  Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.

Authors:  Djemel Hamdane; Chuanwu Xia; Sang-Choul Im; Haoming Zhang; Jung-Ja P Kim; Lucy Waskell
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

Review 8.  Hydrocarbon hydroxylation by cytochrome P450 enzymes.

Authors:  Paul R Ortiz de Montellano
Journal:  Chem Rev       Date:  2010-02-10       Impact factor: 60.622

9.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.

Authors:  P A Williams; J Cosme; V Sridhar; E F Johnson; D E McRee
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

10.  Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.

Authors:  Michael A Noble; Hazel M Girvan; Susan J Smith; W Ewen Smith; Marat Murataliev; Victor M Guzov; René Feyereisen; Andrew W Munro
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

View more
  49 in total

1.  Cytochrome b 5 Is an Obligate Electron Shuttle Protein for Syringyl Lignin Biosynthesis in Arabidopsis.

Authors:  Mingyue Gou; Xiaoman Yang; Yunjun Zhao; Xiuzhi Ran; Yanzhai Song; Chang-Jun Liu
Journal:  Plant Cell       Date:  2019-04-08       Impact factor: 11.277

2.  Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3.

Authors:  Chloe Y S Cheng; Tae-Kang Kim; Saowanee Jeayeng; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-14       Impact factor: 4.292

3.  Molecular dynamics simulations give insight into the conformational change, complex formation, and electron transfer pathway for cytochrome P450 reductase.

Authors:  Axel Sündermann; Chris Oostenbrink
Journal:  Protein Sci       Date:  2013-08-01       Impact factor: 6.725

4.  A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data.

Authors:  Shivani Ahuja; Nicole Jahr; Sang-Choul Im; Subramanian Vivekanandan; Nataliya Popovych; Stéphanie V Le Clair; Rui Huang; Ronald Soong; Jiadi Xu; Kazutoshi Yamamoto; Ravi P Nanga; Angela Bridges; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2013-05-24       Impact factor: 5.157

Review 5.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

6.  Probing the transmembrane structure and dynamics of microsomal NADPH-cytochrome P450 oxidoreductase by solid-state NMR.

Authors:  Rui Huang; Kazutoshi Yamamoto; Meng Zhang; Nataliya Popovych; Ivan Hung; Sang-Choul Im; Zhehong Gan; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

7.  Cytochrome b5 enhances androgen synthesis by rapidly reducing the CYP17A1 oxy-complex in the lyase step.

Authors:  Ruchia Duggal; Ilia G Denisov; Stephen G Sligar
Journal:  FEBS Lett       Date:  2018-06-21       Impact factor: 4.124

Review 8.  Structural diversity of eukaryotic membrane cytochrome p450s.

Authors:  Eric F Johnson; C David Stout
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

9.  Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.

Authors:  Chao Chen; Jingbao Liu; James R Halpert; P Ross Wilderman
Journal:  Biochemistry       Date:  2017-12-19       Impact factor: 3.162

10.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.